Top

Supportive Care in Cancer

Published in:

01-08-2010 | Review Article

Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature

Authors: Michael T. Brennan, Linda S. Elting, Fred K. L. Spijkervet

Published in: Supportive Care in Cancer | Issue 8/2010

Abstract

Background

Oral complications are commonly experienced by patients undergoing cancer therapies. The Oral Care Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO) has completed nine systematic reviews including Bisphosphonate Osteonecrosis of the Jaw, Odontogenic/Periodontal Infection, Dysgeusia, Oral Fungal Infection, Osteoradionecrosis, Trismus, Oral Pain, Oral Viral Infection, and Xerostomia.

Methods

The aims of these reviews were to determine the prevalence of each oral complication, relationship with quality of life, economic impact, and formulation of guidelines based on the quality of the literature. The present article described the details of the methodology and statistical analysis utilized in these nine systematic reviews. Additionally, a summary of the quality of the literature from these oral complications is presented.

Conclusion

Oral complications associated with cancer therapies are common among cancer patients. The systematic reviews by the Oral Care Study Group of MASCC/ISOO provide a thorough assessment of the available literature for these oral complications.

Available only for authorised users

Dreizen S (1990) Description and incidence of oral complications. NCI Monogr 9:11–15PubMed

National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. (1990) NCI Monogr 1-184

National Cancer Institute (2005) Cancer Literature in PubMed. Available from http://www.cancer.gov/search/cancer_literature/. Accessed 26 Sep

Smith BJ, Darzins PJ, Quinn M, Heller RF (1992) Modern methods of searching the medical literature. Med J Aust 157:603–611PubMed

Higgins JP, Green S (2005) Cochrane handbook for systematic reviews of interventions. [cited May 31]. Available from http://www.cochrane.dk/cochrane/handbook/hbook.htm

(1989) Oral complications of cancer therapies: diagnosis, prevention, and treatment. Available from http://consensus.nih.gov/1989/1989OralComplicationsCancerTherapy073html.htm. [cited Apr 17]; 7:1-11

Somerfield MR, Padberg JJ, Pfister DG, Bennett CL, Recht A, Smith TJ, Weeks JC, Winn RJ, Durant JR (2000) ASCO clinical practice guidelines: process, progress, pitfalls, and prospects. Class Pap Curr Comments 4:881–886

Baccaglini L, Brennan MT, Lockhart PB, Patton LL (2007) World Workshop on Oral Medicine IV: process and methodology for systematic review and developing management recommendations. Reference manual for management recommendations writing committees. OOOOE 103 Suppl:S3.e1-19

Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100:2026–2046CrossRefPubMed

10.

Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, Bekele BN, Raber-Durlacher J, Donnelly JP, Rubenstein EB, Mucositis Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology (2004) Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025CrossRefPubMed

11.

Berard A, Bravo G (1998) Combining studies using effect sizes and quality scores: application to bone loss in postmenopausal women. J Clin Epidemiol 51:801–807CrossRefPubMed

12.

Efron B (1993) An introduction to the bootstrap. Chapman & Hall, New York

Title: Systematic reviews of oral complications from cancer therapies, Oral Care Study Group, MASCC/ISOO: methodology and quality of the literature
Authors: Michael T. Brennan
Linda S. Elting
Fred K. L. Spijkervet
Publication date: 01-08-2010
Publisher: Springer-Verlag
Published in: Supportive Care in Cancer / Issue 8/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI: https://doi.org/10.1007/s00520-010-0856-3

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Conclusion

Please log in to get access to this content

Other articles of this Issue 8/2010

Increased blood culture sensitivity in pediatric oncology patients: is it the peripheral culture or increased collected blood volume?

A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact

Characteristics of older newly diagnosed cancer patients refusing cancer treatments

What do palliative care patients and their relatives think about research in palliative care?—a systematic review

Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line

A systematic review of trismus induced by cancer therapies in head and neck cancer patients

Keynote webinar | Spotlight on antibody–drug conjugates in cancer